Literature DB >> 24820795

[Squamous cell carcinoma as the most common oral carcinoma. Diagnosis and therapy].

G Balakirski1, F Hölzle, M Megahed.   

Abstract

BACKGROUND: About 5 % of all malignant tumors affect oral cavity. With a share of 95% squamous cell carcinoma is the most common type of the malignant tumors of oral mucosa. CASE REPORT: In our case the patient developed a squamous cell carcinoma of buccal mucosa about 2 years after excision of verrucous leukoplakia with epithelial dysplasia at the same location. Although chronic alcohol abuse, tobacco use and infection with HPV 16 are the most important risk factors for development of squamous cell carcinoma of the oral cavity, our patient had none of these risk factors. We treated the patient in accordance with current guidelines by complete excision of the tumor as well as an elective neck dissection of the ipsilateral side. Untill the present time the patient is free of recurrence.
CONCLUSIONS: Although rare, squamous cell carcinoma of oral mucosa may also occur in patients that have no risk factors for it. Therefore, every dental and medical examination in each patient should include an inspection of the entire oral mucosa.

Entities:  

Mesh:

Year:  2014        PMID: 24820795     DOI: 10.1007/s00105-014-2790-7

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  16 in total

1.  [Results of the DOSAK tumor register].

Authors:  H P Howaldt; H Vorast; J C Blecher; M Reicherts; M Kainz
Journal:  Mund Kiefer Gesichtschir       Date:  2000-05

2.  Combined effect of tobacco and alcohol on laryngeal cancer risk: a case-control study.

Authors:  R Talamini; C Bosetti; C La Vecchia; L Dal Maso; F Levi; E Bidoli; E Negri; C Pasche; S Vaccarella; L Barzan; S Franceschi
Journal:  Cancer Causes Control       Date:  2002-12       Impact factor: 2.506

3.  Influence of bone invasion and extent of mandibular resection on local control of cancers of the oral cavity and oropharynx.

Authors:  C J O'Brien; J R Adams; E B McNeil; P Taylor; P Laniewski; A Clifford; G D Parker
Journal:  Int J Oral Maxillofac Surg       Date:  2003-10       Impact factor: 2.789

4.  Management of squamous cell carcinoma of the floor of mouth.

Authors:  L W Rodgers; S P Stringer; W M Mendenhall; J T Parsons; N J Cassisi; R R Million
Journal:  Head Neck       Date:  1993 Jan-Feb       Impact factor: 3.147

5.  Management of oral squamous cell carcinoma treated with inadequate excisional biopsy.

Authors:  J S Bailey; R H Blanchaert; R A Ord
Journal:  J Oral Maxillofac Surg       Date:  2001-09       Impact factor: 1.895

6.  The use of clinical criteria alone in the management of the clinically negative neck among patients with squamous cell carcinoma of the oral cavity and oropharynx.

Authors:  C J O'Brien; S J Traynor; E McNeil; J D McMahon; J M Chaplin
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2000-03

7.  Local tumor control in radiation therapy of cancers in the head and neck.

Authors:  P C Levendag; P J Nowak; M J van der Sangen; P P Jansen; W M Eijkenboom; A S Planting; C A Meeuwis; W L van Putten
Journal:  Am J Clin Oncol       Date:  1996-10       Impact factor: 2.339

8.  Tongue cancer treated with brachytherapy: is thickness of tongue cancer a prognostic factor for regional control?

Authors:  H Yamazaki; T Inoue; T Teshima; E Tanaka; M Koizumi; K Kagawa; A Imai; K Yoshida; H Shiomi; K Shimizutani; S Furukawa; H Fuchihata; H Nakamura; T Inoue
Journal:  Anticancer Res       Date:  1998 Mar-Apr       Impact factor: 2.480

9.  Tumor thickness influences prognosis of T1 and T2 oral cavity cancer--but what thickness?

Authors:  Christopher J O'Brien; Christopher S Lauer; Susanne Fredricks; Anthony R Clifford; Edward B McNeil; Jai S Bagia; Christina Koulmandas
Journal:  Head Neck       Date:  2003-11       Impact factor: 3.147

10.  Relevance of positive margins in case of adjuvant therapy of oral cancer.

Authors:  A F Kovács
Journal:  Int J Oral Maxillofac Surg       Date:  2004-07       Impact factor: 2.789

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.